Ensoma
Innovative in vivo treatments using DNA editing to engineer immune cells for curative therapies. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€386m (Public information from May 2023)
Boston Massachusetts (HQ)
Authorizing premium user...